EE03509B2 - Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks - Google Patents

Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks

Info

Publication number
EE03509B2
EE03509B2 EE9700371A EE9700371A EE03509B2 EE 03509 B2 EE03509 B2 EE 03509B2 EE 9700371 A EE9700371 A EE 9700371A EE 9700371 A EE9700371 A EE 9700371A EE 03509 B2 EE03509 B2 EE 03509B2
Authority
EE
Estonia
Prior art keywords
propellantfree
aerosols
generating
medicinal compositions
ethanol containing
Prior art date
Application number
EE9700371A
Other languages
English (en)
Other versions
EE9700371A (et
EE03509B1 (et
Inventor
Bernhard Freund
Michael Krüger
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7765285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03509(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE9700371A publication Critical patent/EE9700371A/et
Publication of EE03509B1 publication Critical patent/EE03509B1/et
Publication of EE03509B2 publication Critical patent/EE03509B2/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Leiutis käsitleb etanooli sisaldavaid ravimikompositsioone, mida kasutatakse kandegaasita aerosoolide saamiseks.
EE9700371A 1995-06-27 1996-06-21 Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks EE03509B2 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19523207 1995-06-27
PCT/EP1996/002700 WO1997001329A1 (de) 1995-06-27 1996-06-21 Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole

Publications (3)

Publication Number Publication Date
EE9700371A EE9700371A (et) 1998-06-15
EE03509B1 EE03509B1 (et) 2001-10-15
EE03509B2 true EE03509B2 (et) 2015-02-16

Family

ID=7765285

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700371A EE03509B2 (et) 1995-06-27 1996-06-21 Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks

Country Status (35)

Country Link
US (5) US6491897B1 (et)
EP (1) EP0835098B1 (et)
JP (1) JP3875993B2 (et)
KR (1) KR100392280B1 (et)
CN (1) CN1086575C (et)
AR (1) AR002614A1 (et)
AT (1) ATE223203T1 (et)
AU (1) AU721566B2 (et)
BG (1) BG64112B1 (et)
BR (1) BR9609307B1 (et)
CA (1) CA2225601C (et)
CZ (1) CZ288337B6 (et)
DE (2) DE59609627D1 (et)
DK (1) DK0835098T3 (et)
EE (1) EE03509B2 (et)
EG (1) EG23912A (et)
ES (1) ES2183001T3 (et)
HU (1) HU223072B1 (et)
IL (1) IL122752A (et)
MX (1) MX9800125A (et)
MY (1) MY116535A (et)
NO (1) NO315452B1 (et)
NZ (1) NZ312662A (et)
PE (1) PE11098A1 (et)
PL (1) PL186196B1 (et)
PT (1) PT835098E (et)
RU (1) RU2223750C2 (et)
SA (1) SA96170213B1 (et)
SI (1) SI0835098T1 (et)
SK (1) SK282468B6 (et)
TR (1) TR199701711T1 (et)
TW (1) TW537903B (et)
UA (1) UA62917C2 (et)
WO (1) WO1997001329A1 (et)
ZA (1) ZA965411B (et)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
ES2183001T3 (es) 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
GB9904281D0 (en) * 1999-02-24 1999-04-21 Reneuron Ltd Transplantation
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US8820316B2 (en) * 2000-02-11 2014-09-02 Respironics Respiratory Drug Delivery (Uk) Ltd Drug delivery apparatus
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
KR100983208B1 (ko) * 2000-10-31 2010-09-20 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 티오트로퓸 염을 함유하는 용액의 흡입성 제형
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
CN1700934B (zh) 2002-09-06 2011-08-03 菲利普莫里斯美国公司 液体气溶胶制剂和用于制备气溶胶的气溶胶产生装置及方法
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7849850B2 (en) * 2003-02-28 2010-12-14 Battelle Memorial Institute Nozzle for handheld pulmonary aerosol delivery device
DE10345065A1 (de) 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
DE102004001451A1 (de) 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
GB0427568D0 (en) * 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
AU2006214166B2 (en) 2005-02-17 2011-09-29 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
EP1850831B1 (en) * 2005-02-25 2015-12-02 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
WO2007094835A1 (en) 2006-02-14 2007-08-23 Ventaira Pharmaceuticals, Inc. Dissociated discharge ehd sprayer with electric field shield
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
CA2741078A1 (en) * 2008-10-23 2010-04-29 Sunovion Pharmaceuticals Inc. Arformoterol and tiotropium compositions and methods for use
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
LT3928818T (lt) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Purkštuvas ir talpa
US10603451B2 (en) 2014-11-20 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Container for an inhaler
CN111939143A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种布地奈德溶液型气雾剂及其制备方法
KR102278414B1 (ko) 2019-12-03 2021-07-16 한전케이피에스 주식회사 벨트 교체용 공구
CN115989032A (zh) 2020-07-31 2023-04-18 化学研究有限公司 用于吸入施用的组合疗法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (et) 1962-05-24
DE1952320C3 (de) 1969-10-17 1981-02-26 Licentia Patent-Verwaltungs-Gmbh, 6000 Frankfurt Vorrichtung zum Abdichten von zwei koaxial ineinander gelagerten um- oder gegenläufigen Wellen bei Wasserfahrzeugen
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
JPS5529524A (en) 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
JPS599539B2 (ja) 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4289764A (en) * 1979-12-04 1981-09-15 Drythanol Ltd. Steroid compositions
DE3109783C2 (de) 1981-03-13 1987-04-02 Schwarz GmbH, 4019 Monheim Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
DE3246081A1 (de) 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
JPS6183117A (ja) 1984-09-28 1986-04-26 Sumitomo Chem Co Ltd エアゾ−ル剤
US4615699A (en) 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE3544692A1 (de) 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
AU6907687A (en) * 1986-02-18 1987-08-20 Rorer Pharmaceutical Corporation Composition for treatment of asthmatic conditions using phenoxymethyl quinolines
JPH0645538B2 (ja) 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
HU199678B (en) * 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5136124A (en) 1988-12-14 1992-08-04 International Business Machines Corporation Method of forming conductors within an insulating substrate
GB8829478D0 (en) 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
US5370862A (en) * 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
IT1243379B (it) 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
DE69105212T2 (de) * 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
NZ243061A (en) * 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
GB9202519D0 (en) 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
DE4203306A1 (de) 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
US5224183A (en) * 1992-07-23 1993-06-29 Alcatel Network Systems, Inc. Multiple wavelength division multiplexing signal compensation system and method using same
WO1994013263A1 (en) 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
DE4340057A1 (de) 1993-11-24 1995-06-01 Falk Pharma Gmbh Budesonid-Arzneimittel zur Verbesserung der enteralen Flüssigkeitsresorption, insbesondere nach postoperativen Zuständen
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
ES2183001T3 (es) 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
US5958378A (en) * 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt

Also Published As

Publication number Publication date
NZ312662A (en) 2001-03-30
JPH11508547A (ja) 1999-07-27
AR002614A1 (es) 1998-03-25
MX9800125A (es) 1998-03-31
EE9700371A (et) 1998-06-15
UA62917C2 (en) 2004-01-15
KR100392280B1 (ko) 2003-11-19
US20060127322A1 (en) 2006-06-15
AU721566B2 (en) 2000-07-06
AU6414496A (en) 1997-01-30
US20080102037A1 (en) 2008-05-01
HU223072B1 (hu) 2004-03-01
US8062626B2 (en) 2011-11-22
NO315452B1 (no) 2003-09-08
SK282468B6 (sk) 2002-02-05
EP0835098B1 (de) 2002-09-04
DE59609627D1 (de) 2002-10-10
BR9609307A (pt) 1999-07-06
BG64112B1 (bg) 2004-01-30
SI0835098T1 (en) 2003-02-28
SK176497A3 (en) 1998-06-03
EP0835098A1 (de) 1998-04-15
KR19990028408A (ko) 1999-04-15
CN1086575C (zh) 2002-06-26
ATE223203T1 (de) 2002-09-15
CN1189096A (zh) 1998-07-29
DK0835098T3 (da) 2002-10-07
RU2223750C2 (ru) 2004-02-20
US20030165435A1 (en) 2003-09-04
EE03509B1 (et) 2001-10-15
NO976084D0 (no) 1997-12-23
CZ288337B6 (en) 2001-05-16
PL324243A1 (en) 1998-05-11
JP3875993B2 (ja) 2007-01-31
US6491897B1 (en) 2002-12-10
WO1997001329A1 (de) 1997-01-16
EG23912A (en) 2007-12-30
NO976084L (no) 1997-12-23
HUP9901710A3 (en) 2000-06-28
TR199701711T1 (xx) 1998-05-21
CZ419297A3 (cs) 1998-06-17
HUP9901710A2 (hu) 1999-10-28
PL186196B1 (pl) 2003-11-28
BR9609307B1 (pt) 2010-03-09
DE19625027A1 (de) 1997-01-02
CA2225601C (en) 2003-10-14
US20020141944A1 (en) 2002-10-03
PT835098E (pt) 2002-12-31
CA2225601A1 (en) 1997-01-16
PE11098A1 (es) 1998-03-17
TW537903B (en) 2003-06-21
ZA965411B (en) 1996-12-27
IL122752A0 (en) 1998-08-16
BG102172A (en) 1998-10-30
ES2183001T3 (es) 2003-03-16
MY116535A (en) 2004-02-28
IL122752A (en) 2001-07-24
SA96170213B1 (ar) 2006-03-06

Similar Documents

Publication Publication Date Title
EE03509B2 (et) Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
HUP9901079A3 (en) 5- and 6-membered cyclic compounds containing nitrogenatom, pharmaceutical compositions containing them, their use for producing pharmaceutical compositions and their producing
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
ZA964337B (en) Pharmaceutical compositions containing irbesartan.
AU6477390A (en) Gas generating compositions containing nitrotriazalone
HUP9900391A3 (en) Pharmaceutical compositions containing rapamycins
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
ZA967034B (en) Pharmaceutical compositions.
EP0831761A4 (en) SILICON DIOXIDE ABRASIVE
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
MX9603203A (es) Composiciones liquidas orales que contienen resinato de paroxetina.
HUP9602489A2 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
AU7727196A (en) Oxygen generating compositions
IL114294A0 (en) Sterol derivatives
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
DE69609652D1 (de) Stabilisator-enthaltende gaserzeugende Zusammensetzungen
GB2304714B (en) New piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
PL319898A1 (en) Cyclosporines containing compositions for oral administration
IL118424A0 (en) Pharmaceutical compositions containing benzimidazole derivative
EG24294A (en) Pharmaceutical compositions
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
GB9506382D0 (en) Pharmaceutical compositions
GB9503066D0 (en) Gas generating composition
AU6908596A (en) Gas generating compositions

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
LD4A Amendment in the specification